Braidwell »

Praxis Precision Medicines I shares owned by Braidwell

Quarter-by-quarter ownership of Praxis Precision Medicines I (PRAX) shares owned by Braidwell from 13F filings

Historical chart of Braidwell investment in Praxis Precision Medicines I

Tip: Access up to 7 years of quarterly data

All positions including Praxis Precision Medicines I held by Braidwell consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Praxis Precision Medicines I by Braidwell

Quarter filed Position value Share count Share price at filing
2026-03-31 $3.2M 10k 322.19

More positions owned by Braidwell

Caris Life Sciences (CAI)
Guardant Health Debt 1.250% 2/1 (Principal)
Repligen Corp Note 1.000%12/1 (Principal)
Neogenomics Note 0.250% 1/1 (Principal)
Neurocrine Biosciences (NBIX)
Glaukos (GKOS)
Centessa Pharmaceuticals Sponsored Ads (CNTA)
Xenon Pharmaceuticals (XENE)
Dianthus Therapeutics (DNTH)
Edgewise Therapeutics (EWTX)
Irhythm Technologies (IRTC)
Nuvalent Inc-a (NUVL)
Kodiak Sciences (KOD)
Cg Oncology (CGON)
Alphatec Hldgs Note 0.750% 3/1 (Principal)

View all positions for Braidwell

Top funds holding Praxis Precision Medicines I

Henderson Group
Orbis Allan Gray
BlackRock
Perceptive Advisors
Baker Bros. Advisors
Vanguard Group
FMR
Vanguard Capital Management
Adage Capital Partners GP
Deerfield Management Company
Driehaus Capital Management
Cormorant Asset Management
State Street Corporation
Morgan Stanley
Vanguard Portfolio Management

View all funds holding Praxis Precision Medicines I